Have you or your loved ones been diagnosed with locally advanced or metastatic solid tumors irrespective of pd-l1 expression?

You may be eligible to participate in a locally advanced or metastatic solid tumors irrespective of pd-l1 expression clinical trial.

Have you or your loved ones been diagnosed with locally advanced or metastatic solid tumors irrespective of pd-l1 expression? You may be eligible to participate in a locally advanced or metastatic solid tumors irrespective of pd-l1 expression clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Locally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 Expression Clinical Trial in Groningen
NCT02453984 | Interventional

Have you or your loved ones been diagnosed with locally advanced or metastatic solid tumors irrespective of pd-l1 expression?

You may be eligible to participate in a locally advanced or metastatic solid tumors irrespective of pd-l1 expression clinical trial.

Have you or your loved ones been diagnosed with locally advanced or metastatic solid tumors irrespective of pd-l1 expression? You may be eligible to participate in a locally advanced or metastatic solid tumors irrespective of pd-l1 expression clinical trial.

Active not recruiting

Male & Female

18 Years +

This study has recruited 45 Participants

By performing a 89Zr-MPDL3280A-PET scan prior or during treatment with MPDL3280A, the uptake of the tracer in the primary and metastatic tumor lesions and normal organ distribution can be evaluated, as well as the use of a 89Zr-MPDL3280A-PET as a complementary tool for patient selection and MPDL3280A- target saturation during treatment.